Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

This publication has 24 references indexed in Scilit:

• Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
  Diabetes, 1998
• Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic Retinopathy
  Ophthalmic Research, 1998
• VEGF localisation in diabetic retinopathy
  British Journal of Ophthalmology, 1998
• Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes
  Diabetologia, 1997
• Localization of Vascular Endothelial Growth Factor in Human Retina and Choroid
  Archives of Ophthalmology (1950), 1996
• Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman Primate
  Archives of Ophthalmology (1950), 1996
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
  Proceedings of the National Academy of Sciences, 1995
• Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
  New England Journal of Medicine, 1994
• Detection of Vascular Endothelial Growth Factor Messenger RNA and Vascular Endothelial Growth Factor-like Activity in Proliferative Diabetic Retinopathy
  Archives of Ophthalmology (1950), 1994
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy
  American Journal of Ophthalmology, 1994